During the corresponding time, Caris Life Sciences Inc recorded a revenue increase by 45.38 % year on year, sequentially revenue grew by 21.99 %. While revenue at the Caris Life Sciences Inc 's corporate clients
Caris Life Sciences Inc's Comment on Sales, Marketing and Customers
The company serves over 6,000 ordering physicians in the United States across major health systems, academic cancer institutions, and community settings, specializing in precision oncology. It provides physicians and patients with actionable information throughout the disease journey. The company also offers solutions to biopharmaceutical companies to support advances in personalized medicine and accelerate the development of novel therapeutics. Its offerings include tissue-based profiling, blood-based profiling for early detection, minimal residual disease (MRD), and monitoring, as well as Caris Assure, a whole exome sequencing (WES) and whole transcriptome sequencing (WTS) blood-based solution for therapy selection with Medicare and commercial payer reimbursement in the U.S., excluding New York. Customers and markets referenced in filings include AdvancePCS Inc., CareMark, Caris Diagnostics, and Miraca Life Sciences.
Caris Life Sciences Inc’s Comment on Sales, Marketing and Customers
The company serves over 6,000 ordering physicians in the United States across major health systems, academic cancer institutions, and community settings, specializing in precision oncology. It provides physicians and patients with actionable information throughout the disease journey. The company also offers solutions to biopharmaceutical companies to support advances in personalized medicine and accelerate the development of novel therapeutics. Its offerings include tissue-based profiling, blood-based profiling for early detection, minimal residual disease (MRD), and monitoring, as well as Caris Assure, a whole exome sequencing (WES) and whole transcriptome sequencing (WTS) blood-based solution for therapy selection with Medicare and commercial payer reimbursement in the U.S., excluding New York. Customers and markets referenced in filings include AdvancePCS Inc., CareMark, Caris Diagnostics, and Miraca Life Sciences.
Sources:
Caris Life Sciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Caris Life Sciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Caris Life Sciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
175.59 %